Godfrey Phillips India (500163) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
19 Nov, 2025Executive summary
Consolidated gross sales value for H1 FY25 reached Rs 6,668 crore, up 23% year-over-year; net profit before exceptional items was Rs 522 crore, up 14% year-over-year.
Board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2024, with limited review by auditors and no material misstatements found.
Robust domestic cigarette volume growth and strong unmanufactured tobacco exports supported topline performance.
Announced introduction of an Employee Share Purchase Scheme (ESPS 2024), subject to shareholder approval.
Initiated closure of the Retail Business Division (24Seven), with related exceptional loss recognized.
Financial highlights
Gross profit for H1 FY25 was Rs 1,122 crore with a margin of 16.8%; EBITDA stood at Rs 537 crore, up 12.8% year-over-year.
Standalone revenue from operations for Q2 FY25 was ₹164,885 lakhs, up from ₹137,574 lakhs in Q2 FY24.
Consolidated net profit for Q2 FY25 was ₹24,831 lakhs, up from ₹20,206 lakhs in Q2 FY24; H1 FY25 net profit was ₹47,686 lakhs.
Domestic gross sales value from tobacco was Rs 5,676 crore, contributing 98% to total gross sales.
International gross sales value was Rs 831 crore; retail business gross sales value was Rs 127 crore.
Outlook and guidance
Plans underway to enter new markets and launch new offerings, with a focus on sustaining growth momentum.
Strategic priorities include strengthening the core business, expanding international operations, and leveraging distribution partnerships.
Management reaffirmed the reasonableness of exceptional loss estimates related to the retail business exit.
Latest events from Godfrey Phillips India
- Gross sales and net profit surged, with bonus shares, dividend, and insurance claim for fire loss.500163
Q3 25/2630 Jan 2026 - 25% profit growth, retail exit, and interim dividend highlight 9M FY25 results.500163
Q3 24/2519 Nov 2025 - Double-digit sales growth and tobacco strength offset by retail exit loss and leadership changes.500163
Q1 24/2519 Nov 2025 - Sales and profit surged, Rs. 17 interim dividend and 2:1 bonus shares issued.500163
Q2 25/2610 Nov 2025 - Strong profit growth, 2:1 bonus share issue, and robust tobacco segment performance.500163
Q1 25/268 Aug 2025 - Gross sales rose 34%, net profit up 21%, and retail business exited; Rs 95/share dividend.500163
Q4 24/256 Jun 2025